Agent- 86
Your guess on this is as good as mine because I really don’t know.
All I can offer is a couple of observations.
Firstly, as I think I’ve said before, if NNZ-2591 is successful in Phase 2 PMD, I think it unlikely that Neuren will be running a Phase 3 trial in PMD or any other indication. My feeling is that, whether we like it or not, it will be Acadia running the show.
That said, I believe that Neuren will continue to work towards making NNZ-2591 a Phase 3-ready asset by completing all the necessary manufacturing requirements (very important step) and meeting with the FDA (and possibly EMA) in a post-Phase 2 meeting to ascertain what the FDA’s pivotal trial requirements are. With respect to trial design, I think that any potential acquirer would prefer to control that.
The clinical trials website suggests that there has been just one Phase 3 trial commenced in PMD, which is still in progress – and that’s a randomized, double-blind placebo-controlled 12 week treatment trial in 7-18 yr olds with PMD and ASD, using a pre-existing drug (lithium). There appears to be just one recruitment site in Paris, and they are aiming to enrol just 22 patients and expect that to take 2 years.
Other current Phase 2 trials in PMD are small (in a couple of cases, just 6 participants) and recruiting at just one or two sites.
However, I’d expect any Phase 3 trial of NNZ-2591 in PMD to be considerably larger than the current Phase 2, where all 20 participants are receiving the drug.
- Forums
- ASX - By Stock
- NEU
- Phelan-McDermid Syndrome
Phelan-McDermid Syndrome, page-72
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 11501 | $13.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 1539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 464 | 13.100 |
2 | 264 | 13.070 |
1 | 300 | 13.020 |
2 | 300 | 13.010 |
9 | 17634 | 13.000 |
Price($) | Vol. | No. |
---|---|---|
13.210 | 1700 | 1 |
13.430 | 2400 | 1 |
13.450 | 150 | 1 |
13.480 | 2000 | 1 |
13.490 | 1700 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |